Pacer Advisors, Inc. Atara Biotherapeutics, Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$12.89 - $16.58 $59,397 - $76,400	-4,608 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$14.0 - $20.72 $21,756 - $32,198	1,554 Added 50.88%	4,608 $66,000
Q4 2020 Jan 20, 2021	SELL	$12.67 - $26.23 $11,656 - $24,131	-920 Reduced 23.15%	3,054 $60,000
Q3 2020 Oct 19, 2020	BUY	$11.92 - $15.87 $47,370 - $63,067	3,974 New	3,974 $52,000
Q4 2018 Feb 13, 2019	SELL	$30.9 - $42.97 $160,618 - $223,358	-5,198 Closed	0 $0

Q3 2018 Nov 14, 2018	BUY	$35.05 - $43.5 $182,189 - $226,113	5,198 New	5,198 $215,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $710M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.